Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer

by Davide Ciardiello, Giulia Martini, Vincenzo Famiglietti, Stefania Napolitano, Vincenzo De Falco, Teresa Troiani, Tiziana Pia Latiano, Javier Ros, Elena Elez Fernandez, Pietro Paolo Vitiello, Evaristo Maiello, Fortunato Ciardiello, Erika Martinelli
Published 2021-04-01

Genomic Profiling of <i>KRAS/NRAS/BRAF/PIK3CA</i> Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EG...

by Anna Maria Rachiglio, Matilde Lambiase, Francesca Fenizia, Cristin Roma, Claudia Cardone, Alessia Iannaccone, Antonella De Luca, Marianeve Carotenuto, Daniela Frezzetti, Erika Martinelli, Evaristo Maiello, Fortunato Ciardiello, Nicola Normanno
Published 2019-06-01

Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II st...

by M. Yu. Fedyanin, L. Yu. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. L. Popova, N. M. Tikhanovskaya, E. A. Kalabanova, Е. G. Panina, A. I. Arzamastseva, E. G. Rybakov, L. V. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. A. Pokataev, A. A. Tryakin, O. V. Sekhina, D. A. Chekini, Kh. Kh.-M. Elsnukaeva, D. V. Podluzhniy, S. A. Tjulandin, O. I. Kit
Published 2019-06-01

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients

by Pau Riera, Benjamín Rodríguez-Santiago, Adriana Lasa, Lidia Gonzalez-Quereda, Berta Martín, Juliana Salazar, Ana Sebio, Anna C. Virgili, Jordi Minguillón, Cristina Camps, Jordi Surrallés, David Páez
Published 2020-08-01

Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment

by E. A. Shatokhina, L. S. Kruglova, A. S. Polonskaia
Published 2020-12-01

Heterogeneity and clonal evolution of colorectal cancer

by M. Yu. Fedyanin, H. H.-M. Elsnukaeva, S. A. Tjulandin
Published 2017-04-01

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

by Chen Gang, Kronenberger Peter, Teugels Erik, Umelo Ijeoma, De Grève Jacques
Published 2012-03-01

The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic...

by Lauren C. Bylsma, Rebecca Dean, Kimberly Lowe, Laura Sangaré, Dominik D. Alexander, Jon P. Fryzek
Published 2019-09-01

Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study

by Takahiro Arai, Yukiyoshi Fujita, Hisao Imai, Hiroe Matsumoto, Miho Yamazaki, Eriko Hiruta, Yuka Suzuki, Hitoshi Ojima, Hisashi Hosaka, Koichi Minato, Taeko Saito
Published 2021-08-01

Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective S...

by Qing D, Wu Y, Liu X, Jiang H, Zhu C, Liu P, Dang J, Li X, Chen Z, Long X, Pang Q, Peng L, Deng S, Gu J, Zhao R, Chen C, Lu H
Published 2020-12-01

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

by Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J
Published 2018-07-01